Thermasolutions
ThermaSolutions is a privately held medical device company that designs and distributes HIPEC and PIPAC hyperthermic chemotherapy systems, plus single-use disposables, to surgical oncologists and hospitals across more than 50 countries.
- Company typePrivate
- Founded1999
- HeadquartersWhite Bear Lake, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Thermasolutions does
ThermaSolutions is a privately held medical device company founded in 1999 and headquartered in White Bear Lake, Minnesota, with wholly-owned operating entities in Breda, Netherlands (ThermaSolutions BV) and Kerala, India (ThermaSolutions India). The company designs, manufactures, and distributes the ThermoChem family of hyperthermic intraperitoneal chemotherapy (HIPEC) systems — including the FDA-cleared HT-2000 and CE-marked HT-2500 — which deliver heated chemotherapy into the peritoneal cavity during cytoreductive surgery at therapeutic temperatures of approximately 42–43°C. Its portfolio also includes the HurriChem Device Kit (FDA) and HurriChem Nebulizer (CE) for Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC), the HEATT whole-body hyperthermia system co-marketed with Verthermia, Isolated Limb Infusion/Perfusion kits, and a recurring line of single-use disposable procedure kits, chemo waste products, and thermal insulators. The company positions itself as the only vendor offering both open HIPEC and laparoscopic PIPAC delivery options for peritoneal surface malignancies.
ThermaSolutions serves surgical oncologists, gynecological oncologists, and the cancer centers and hospitals where they practice, targeting indications including colorectal peritoneal metastasis, ovarian cancer, pseudomyxoma peritonei, and appendix cancer. Its go-to-market combines direct field sales to major cancer centers with a global distributor network spanning more than 50 countries and 300+ hospital sites; named institutional users include Cleveland Clinic, Tufts Medical Center, The Christie NHS Foundation Trust, Cambridge University Hospital, Stony Brook Medicine, and Mercy Hospital Baltimore. Marketing is anchored in conference presence (SSO, SGO, ESSO, ISSPP, PSOGI) and physician training programs, supplemented by patient-advocacy partnerships with ACPMP, PMP Pals, and the HIPEC Registry.
The business model is hardware sales of capital equipment (HT-2000, HT-2500, HEATT) plus recurring revenue from single-use disposable procedure kits and accessories, which are designed to drive per-procedure pull-through. Quality and regulatory posture is grounded in EN/ISO 13485:2016, 21 CFR Part 820, and MDSAP certification, supporting multi-jurisdiction commercialization. Revenue, funding history, and ownership structure beyond the founding leadership are not publicly disclosed; the company has been led by CEO Steven Davis since 2021 following the retirement of founders Willem and Lenie ter Stege.
Thermasolutions firmographics
Firmographics- Name
- Thermasolutions
- Legal name
- ThermaSolutions Inc.
- Website
- https://thermasolutions.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ThermaSolutions is a privately held medical device company that designs and distributes HIPEC and PIPAC hyperthermic chemotherapy systems, plus single-use disposables, to surgical oncologists and hospitals across more than 50 countries.
- Ownership category
- akta.pro rank
Where Thermasolutions is headquartered
LocationHeadquarters
- HQ city
- White Bear Lake
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Thermasolutions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of HIPEC systems (ThermoChem HT-2000, HT-2500), HurriChem devices, disposable procedure kits, and related surgical oncology products to hospitals and cancer treatment centers.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Thermasolutions product offering
Product offeringCore offering
ThermaSolutions manufactures and sells hyperthermic medical devices for cancer treatment, including the ThermoChem HT-2000 and HT-2500 systems that deliver Hyperthermic Intraperitoneal Chemotherapy (HIPEC) during cytoreductive surgery, and the HurriChem nebulizer/device kits for Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC). The company also offers the HEATT whole body hyperthermia system in partnership with Verthermia and a range of disposable procedure kits and accessories for surgical oncology use in hospitals and cancer treatment centers.
Product overview
ThermaSolutions is a medical device company offering the ThermoChem family of hyperthermic systems and customized disposables for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and laparoscopic aerosolization treatments. The product portfolio centers on the ThermoChem HT-2000 and HT-2500 devices for HIPEC procedures, supplemented by the HurriChem Device Kit and Nebulizer for PIPAC (Pressurized Intraperitoneal Aerosolized Chemotherapy) treatments. Additional offerings include Whole Body Hyperthermia (HEATT), Isolated Limb products, and a comprehensive range of disposable accessories including procedure kits, chemo waste products, thermal insulators, tubing drains, and accessories. The company positions itself as the only provider offering both HIPEC and laparoscopic aerosolization options for cancer treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- ThermoChem HT-2000
Quantifiable outcome
- Improved recurrence-free survival and overall survival in stage III ovarian cancer patients receiving HIPEC (hazard ratio 0.66 for recurrence, 0.67 for death)
- +2 more outcomes
Companies that use Thermasolutions
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Thermasolutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Thermasolutions partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Tehnoplus (Romania)coreNew HIPEC and PIPAC distributor in Romania. Partnership facilitated through Prof. Dr. Cătălin Copăescu and attendance at ISSPP PIPAC Training and Central & Eastern Europe ISSPP PIPAC Workshop.
- Bioargo (Brazil)coreNew distributor in Brazil announced at 5th International Congress of ISSPP in São Paulo. ThermaSolutions is launching services in Brazil in 2026.
- Syno Medical (Malaysia)coreDistributor partner in Malaysia, participated in 20th Asia-Pacific Federation of Coloproctology Congress.
- DMedCare (Taiwan)corePartnership to bring HIPEC and PIPAC services to Taiwan, announced November 2024.
- Frimed (Chile)coreDistributor in Chile supporting Latin American market, exhibited at 4th Congreso Latinoamericano de Neoplasias Peritoneales in Frutillar, Chile.
- Ibersurgical (Spain)minorSpanish distributor partner for SEOQ/GECOP Virtual Workshop support in 2021.
- Verthermia (HEATT)corePartnership with Verthermia for Whole Body Hyperthermia using HEATT system, providing treatment for advanced unresponsive cancer with local physicians.
- HIPEC RegistryminorPartner organization supporting peritoneal surface malignancy patient registry and awareness.
- ACPMP Research FoundationminorProud supporter of ACPMP and cancer research for Pseudomyxoma Peritonei, Appendix Cancer, and related PSM. Platinum sponsor of annual walk/run events.
- PMP PalsminorPatient support organization for Pseudomyxoma Peritonei, partnered for awareness campaigns.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Thermasolutions competitors and assessment
Company assessmentDirect peers
- PFM Medical: German medical device company producing hyperthermic chemotherapy systems and surgical oncology consumables. Overlaps with ThermaSolutions in HIPEC hardware and disposables for European hospital customers.
- MTRE Advanced Technologies: Israeli medical device company specializing in hyperthermic perfusion systems for oncology and limb salvage. Competes with ThermaSolutions in HIPEC equipment for surgical oncology applications.
- Sennewald Medizintechnik: German manufacturer of hyperthermia and HIPEC equipment for cancer treatment. Direct competitor in European oncology device market with comparable thermal chemotherapy delivery systems.
- RanD Biotech: Italian manufacturer of HIPEC and PIPAC devices used in cytoreductive surgery. Most direct head-to-head competitor to ThermaSolutions' ThermoChem and HurriChem product lines in European and international markets.
- Belmont Instrument (hyperthermia division): US-based manufacturer of rapid infusion and hyperthermia perfusion systems used in surgical oncology. Competes directly with ThermaSolutions in the US hospital market for heated chemotherapy delivery equipment.
Broad incumbents
- STERIS (formerly Cantel Medical / Medivators): Large medical device and infection prevention company with surgical oncology adjacencies through its endoscopy and sterilization portfolios. Potential strategic competitor or acquirer in the surgical oncology device space.
- Becton, Dickinson and Company (BD): Large diversified medical device company with significant presence in surgical and oncology drug delivery. Represents a strategic incumbent with resources to enter or consolidate the hyperthermia device space.
- Medtronic: Global medical device leader with surgical and oncology franchises. Broad incumbent in the same hospital customer ecosystem with resources to enter hyperthermic oncology devices.
Emerging players
- Combat Medical: UK-based company focused on pressurized intraperitoneal aerosol chemotherapy (PIPAC) technology. Direct PIPAC modality competitor, intersecting with ThermaSolutions' HurriChem product line.
- AngioDynamics: US medical device company with oncology-focused therapy delivery and ablation products. Adjacent competitor in interventional and surgical oncology with potential overlap in isolated limb perfusion offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Thermasolutions social profiles
Digital presenceThermasolutions compliance and trust
Trust signalCompliance2 records
Thermasolutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thermasolutions leadership team
Management profileNumber of profiles
Profiles2 records
Thermasolutions subsidiaries and ownership
Company hierarchySubsidiaries2 records
Thermasolutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thermasolutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thermasolutions
What does Thermasolutions do?
ThermaSolutions manufactures and sells hyperthermic medical devices for cancer treatment, including the ThermoChem HT-2000 and HT-2500 systems that deliver Hyperthermic Intraperitoneal Chemotherapy (HIPEC) during cytoreductive surgery, and the HurriChem nebulizer/device kits for Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC). The company also offers the HEATT whole body hyperthermia system in partnership with Verthermia and a range of disposable procedure kits and accessories for surgical oncology use in hospitals and cancer treatment centers.
Is Thermasolutions a public or private company?
Thermasolutions is a private company. It is classified as unknown and is currently operating.
When was Thermasolutions founded?
Thermasolutions was founded in 1999. It employs 11 to 50 people.
Where is Thermasolutions based?
Thermasolutions is headquartered in White Bear Lake, United States, in the North America region.
How does Thermasolutions make money?
One revenue line is on record: medical Device Sales.
Who are Thermasolutions's main competitors?
Direct peers on record are PFM Medical, MTRE Advanced Technologies, Sennewald Medizintechnik, RanD Biotech and Belmont Instrument (hyperthermia division). Broad incumbents are STERIS (formerly Cantel Medical / Medivators), Becton, Dickinson and Company (BD) and Medtronic. Emerging players are Combat Medical and AngioDynamics.
Does Thermasolutions have an API?
No public API is recorded for Thermasolutions.